Fox Chase Cancer Center News

PHILADELPHIA (February 18, 2016) — Robert G. Uzzo, MD, FACS, a nationally recognized leader in urologic oncology from Fox Chase Cancer Center–Temple Health, is the recent recipient of the 36th Annual Ralph E. Hopkins Jackson Hole Seminar Series in Urology Award.

PHILADELPHIA (February 16, 2016) – Phenylketonuria, also known as PKU, is the most common inherited disease affecting amino acid metabolism. In a study published February 15^th in Proceedings of the National Academy of Sciences, Fox Chase Cancer Center – Temple Health researchers made tremendous strides toward that goal by shedding new light on the structure of phenylalanine hydroxylase (PAH)—the enzyme that is defective in PKU patients.

PHILADELPHIA (February 16, 2016) – Fox Chase Cancer Center – Temple Health researchers have identified a way forward for personalized cancer treatments for a wide range of cancers by understanding how to stimulate the activity of a potent anticancer protein called TRAIL. ONC201 not only stimulates TRAIL, but also the death receptor for TRAIL on tumor cells.

PHILADELPHIA (February 2, 2016) – While its overall incidence has decreased in recent years, ovarian cancer causes more deaths than any other cancer of the female reproductive system, ranking fifth in cancer deaths among women. This February, Fox Chase Cancer Center—Temple Health seeks to educate women on the risk factors and signs of ovarian cancer.

(PHILADELPHIA, January 27, 2016) — HPV vaccination represents a rare opportunity to prevent many cases of cancer that is tragically underused. According to a 2015 CDC report, only 40 percent of girls and 21 percent of boys in the U.S. are receiving the recommended three doses of the HPV vaccine.

PHILADELPHIA (January 22, 2016) – The  Fox Chase Cancer Center’s American Cancer Society Institutional Research Grant (IRG) Pilot Project Competition for Junior Investigators  was open to eligible junior faculty at Fox Chase Cancer Center or Temple University. 

PHILADELPHIA (January 22, 2016) – A multidisciplinary team of physicians from Fox Chase Cancer Center – Temple Health and the Temple University School of Medicine has compiled a comprehensive review of recent advances in the understanding, diagnosis, and treatment of bile ducts cancers (or cholangiocarcinomas). The review is published in the January 22^nd issue of Cancer.

PHILADELPHIA (January 18, 2016)  – Forty-four Temple University Health System (TUHS) physicians, including 26 at Fox Chase Cancer Center, have recently been named America’s Top Doctors® for 2016 by Castle Connolly Medical Ltd., a health care research and information company.